Jan 8 (Reuters) - MEI Pharma Inc:
* MEI PHARMA ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR CDK INHIBITOR VORUCICLIB
* MEI PHARMA INC - LOOK FORWARD TO ADVANCING VORUCICLIB THROUGH CLINIC IN Q2 OF 2018 Source text for Eikon: Further company coverage:
 